Deborah A. Tweddle

3.6k total citations
64 papers, 2.2k citations indexed

About

Deborah A. Tweddle is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Deborah A. Tweddle has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Neurology, 27 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Deborah A. Tweddle's work include Neuroblastoma Research and Treatments (49 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Cancer-related Molecular Pathways (17 papers). Deborah A. Tweddle is often cited by papers focused on Neuroblastoma Research and Treatments (49 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Cancer-related Molecular Pathways (17 papers). Deborah A. Tweddle collaborates with scholars based in United Kingdom, United States and Italy. Deborah A. Tweddle's co-authors include John Lunec, Nicola J. Curtin, Andrew D.J. Pearson, Harriet Southgate, Emma Bell, Archie J. Malcolm, Lindi Chen, Michael Cole, Ursula R. Kees and Katrina Wood and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Cancer Research.

In The Last Decade

Deborah A. Tweddle

62 papers receiving 2.2k citations

Peers

Deborah A. Tweddle

NEURO

ONCOL

GENET

Jessica L. Bell Australia

Aaron C. Spalding United States

Shweta Joshi United States

Stefania Beghelli Italy

Qiao‐Nan Guo China

Ronald W. Stam Netherlands

Yari Ciani Italy

Deepali Sachdev United States

Rossella Rota Italy

Robert L. Redner United States

Jessica L. Bell Australia

Deborah A. Tweddle

1.8k ×1.4

144 ×0.1

NEURO

433 ×0.5

ONCOL

951 ×1.3

107 ×0.6

GENET

Citations per year, relative to Deborah A. Tweddle Deborah A. Tweddle (= 1×) peers Jessica L. Bell

Countries citing papers authored by Deborah A. Tweddle

Since Specialization

Citations

This map shows the geographic impact of Deborah A. Tweddle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Tweddle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Tweddle more than expected).

Fields of papers citing papers by Deborah A. Tweddle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Tweddle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Tweddle. The network helps show where Deborah A. Tweddle may publish in the future.

Co-authorship network of co-authors of Deborah A. Tweddle

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah A. Tweddle. A scholar is included among the top collaborators of Deborah A. Tweddle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah A. Tweddle. Deborah A. Tweddle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weir, Laura K., et al.. (2023). Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma. Cancers. 15(21). 5233–5233. 3 indexed citations

Hayes, Louise, Nermine O. Basta, C R Muirhead, et al.. (2022). Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada. Environmental Health. 21(1). 30–30. 1 indexed citations

Wen, Hao, John M. Maris, Shahab Asgharzadeh, et al.. (2022). Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma. British Journal of Cancer. 127(11). 2006–2015. 14 indexed citations

Barnett, S., Guy Makin, Deborah A. Tweddle, et al.. (2021). Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients. European Journal of Cancer. 164. 127–136. 22 indexed citations

Chen, Lindi, Mark Brougham, Guy Makin, et al.. (2019). Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers. Clinical Cancer Research. 26(1). 122–134. 29 indexed citations

Basta, Nermine O., et al.. (2019). A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma. European Journal of Cancer. 111. 50–58. 24 indexed citations

Chen, Lindi, Fabio Pastorino, Philip Berry, et al.. (2018). Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma. International Journal of Cancer. 144(12). 3146–3159. 26 indexed citations

Basta, Nermine O., Guy Makin, Jillian M. Birch, et al.. (2016). Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. British Journal of Cancer. 115(9). 1048–1057. 61 indexed citations

Veal, Gareth J., Julie Errington, James Hayden, et al.. (2015). Carboplatin therapeutic monitoring in preterm and full-term neonates. European Journal of Cancer. 51(14). 2022–2030. 30 indexed citations

10.

Barone, Giuseppe, Deborah A. Tweddle, Jason M. Shohet, et al.. (2014). MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance. Current Drug Targets. 15(1). 114–123. 33 indexed citations

11.

Bell, Emma, Frida Ponthan, Claire Whitworth, et al.. (2014). COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib. Clinical & Experimental Metastasis. 31(6). 651–659. 6 indexed citations

12.

Fisher, Jonathan & Deborah A. Tweddle. (2012). Neonatal neuroblastoma. Seminars in Fetal and Neonatal Medicine. 17(4). 207–215. 58 indexed citations

13.

Gamble, Laura D., Ursula R. Kees, Deborah A. Tweddle, & John Lunec. (2011). MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63. Oncogene. 31(6). 752–763. 56 indexed citations

14.

Chen, Lindi, Nunzio Iraci, Samuele Gherardi, et al.. (2010). p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma. Cancer Research. 70(4). 1377–1388. 98 indexed citations

15.

Rozanska, Agata, Huw D. Thomas, Evan A. Mulligan, et al.. (2009). Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma. Clinical Cancer Research. 15(4). 1241–1249. 61 indexed citations

16.

Moore, Hannah C., Katrina Wood, Michael S. Jackson, et al.. (2008). Histological profile of tumours from MYCN transgenic mice. Journal of Clinical Pathology. 61(10). 1098–1103. 33 indexed citations

17.

Bown, Nick, et al.. (2007). High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. Cancer Genetics and Cytogenetics. 172(2). 127–138. 29 indexed citations

18.

Chen, Lindi, Archie J. Malcolm, Katrina Wood, et al.. (2007). p53 is Nuclear and Functional in Both Undifferentiated and Differentiated Neuroblastoma. Cell Cycle. 6(21). 2685–2696. 36 indexed citations

19.

Tornóczky, Tamás, Endre Kálmán, P. Kajtár, et al.. (2004). Large cell neuroblastoma. Cancer. 100(2). 390–397. 26 indexed citations

20.

Tweddle, Deborah A., Andrew D.J. Pearson, Michelle Haber, et al.. (2003). The p53 pathway and its inactivation in neuroblastoma. Cancer Letters. 197(1-2). 93–98. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact